Fluid therapy

Goal-directed fluid therapy on the prognosis of patients during elective total hip arthroplasty

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-14005195

Enrollment

Unknown

Registered

2014-09-03

Start date

2014-10-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hip osteoarthritis

Interventions

the traditional fluid therapy group:Empirical formula fluid therapy

Goal-directed fluid therapy group:Goal-directed fluid therapy

Eligibility

Age

65 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) age older than 65 years of age; (2) diagnosis of hip osteoarthritis; (3) voluntarily participated in the study, written informed consent and agree to postoperative follow-up.

Exclusion criteria

Exclusion criteria: (1) water, electrolyte and acid-base balance disorders; (2) heart, lung, liver, kidney or other vital organ dysfunction; (3) body mass index more than 30 kg/m2; (4) allergic to colloidal solutions or intraoperative anesthetic drugs; (5) do not want to participate in this research.

Design outcomes

Primary

Measure	Time frame
Heart Rate;Blood Pressure;Electrocardiogram;Oxygenation index;Creatinine;Blood urea nitrogen;Platelet;Prothrombin time;Activated partial thromboplastin time;D-dimer;Albumine;Bilirubine;Hemoglobine;	—

Countries

China

Contacts

Public ContactGeng Wang

w_geng@163.com+86 13910676672

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026